Hemagen Diagnostics 

$0.000200
6
-$0.00-92.31%Tuesday 20:00

Statistics

Day High
0.015
Day Low
0.015
52W High
0.1251
52W Low
0.0001
Volume
50,000
Avg. Volume
50
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Feb 14Expected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories competes in the diagnostics segment, offering a broad range of diagnostic tests and instruments that overlap with Hemagen's product offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories provides a variety of clinical diagnostics and life science research products, directly competing with Hemagen's diagnostic solutions.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation, through its subsidiaries, offers a wide array of biomedical testing products and services, including diagnostics solutions that compete with Hemagen.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers a comprehensive range of diagnostics and research products, competing in the same space as Hemagen Diagnostics.
Resmed
RMD
Mkt Cap32.34B
ResMed Inc. specializes in products for diagnosing and treating respiratory disorders, potentially overlapping with Hemagen's diagnostic solutions in certain healthcare settings.
QuidelOrtho
QDEL
Mkt Cap908.62M
Quidel Corporation specializes in diagnostic healthcare products that could compete with Hemagen Diagnostics in the areas of infectious disease testing.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation offers scientific instruments and diagnostic assays that could compete with Hemagen's product line in specialized diagnostic applications.
Agilent Technologies
A
Mkt Cap49.3B
Agilent Technologies provides laboratories worldwide with instruments, services, consumables, applications, and expertise, competing with Hemagen in the diagnostics market.

About

Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
Show More
CEO
William Hales
Employees
15
Country
United States
ISIN
US4235011057

Listings

0 Comments

Share your thoughts

FAQs

What is Hemagen Diagnostics stock price today?▼
The current price of HMGN is $0.00 USD — it has decreased by -92.31% in the past 24 hours. Watch Hemagen Diagnostics stock price performance more closely on the chart.
What is Hemagen Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Hemagen Diagnostics stocks are traded under the ticker HMGN.
Is Hemagen Diagnostics stock price growing?▼
HMGN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Hemagen Diagnostics has showed a +100% increase.
How many employees does Hemagen Diagnostics have?▼
As of November 2, 2026, the company has 15 employees.
In which sector is Hemagen Diagnostics located?▼
Hemagen Diagnostics operates in the Health & Wellness sector.
When did Hemagen Diagnostics complete a stock split?▼
Hemagen Diagnostics has not had any recent stock splits.
Where is Hemagen Diagnostics headquartered?▼
Hemagen Diagnostics is headquartered in Columbia, United States.